Clinical Consequences of Heart Treatment Following the TACT Study

The TACT Study published in November 2013 by NIH shows significant impact on heart disease using the chelation method. In this case, using the clinical treatment and the annual exam based on Cleveland Heart Clinic blood tests on the basis for the MDVIP program sponsored by the Procter & Gamble Co. The program has been carried out over a 5 year period and the results are reported here for a single patient. The test shows the impact on the heart, the blood sugar, the myeloperoxidase,the LDL,the HDL, the TSH, and the blood pressure.